Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

National Yang Ming Chiao Tung University Hospital clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Taiwan register with National Yang Ming Chiao Tung University Hospital as lead sponsor. Synced 17 Nov 2026
4Current trials
0Recruiting now
1Drug in these trials
1Trial register
At a glance

National Yang Ming Chiao Tung University Hospital is the lead sponsor of 4 current clinical trials in our Taiwan register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Not applicable. The drugs named most often in its trials are Atropine. The most-studied condition is Myopia.

ClinicalTrials.gov trials by status

  • Not yet open250%
  • Active, closed250%

Trials by phase

  • Not applicable250%
  • Phase 2125%
  • Observational125%
01

Clinical trials sponsored by National Yang Ming Chiao Tung University Hospital

4 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Barriers and Facilitators to Nursing Record With AI Technology Application
NCT07532343 · ClinicalTrials.gov ↗ · Implementation Research, Artificial Intelligence (AI), Nursing Documentation Burden
Observational Not yet open 2026-05 Taiwan
Effectiveness of Active Cycle of Breathing Techniques in Patients With Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
NCT07818187 · COPD (Chronic Obstructive Pulmonary Disease)
Not applicable Not yet open 2026-09 Taiwan
Early Intervention for Premyopic Children
NCT06200194 · ClinicalTrials.gov ↗ · Myopia, Preschool
Drug: Atropine
Phase 2 Active, closed 2024-10 Taiwan
VR Learning Program for Sexual-and-gender-diversity Care
NCT07535216 · ClinicalTrials.gov ↗ · Sex Difference, Virtual Care, Nursing Care
Not applicable Active, closed 2025-08 Taiwan

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in National Yang Ming Chiao Tung University Hospital trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in National Yang Ming Chiao Tung University Hospital trials

9 conditions
Myopia1Preschool1Implementation Research1Artificial Intelligence (AI)1Nursing Documentation Burden1Sex Difference1Virtual Care1Nursing Care1COPD (Chronic Obstructive Pulmonary Disease)1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in Taiwan40

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Myopia

SponsorTrials
Shanghai Eye Disease Prevention and Treatment Center13
Essilor International10
SightGlass Vision9
Beijing Tongren Hospital6
Zhongshan Ophthalmic Center, Sun Yat-sen University6
Ruihua Wei5
Singapore National Eye Centre5
CooperVision International Limited (CVIL)4
nthalmic3
Beijing Visionly Plus Eye Hospital3

Sponsors with the most current trials registered for this condition.

06

Questions about National Yang Ming Chiao Tung University Hospital trials

How many clinical trials does National Yang Ming Chiao Tung University Hospital sponsor?

National Yang Ming Chiao Tung University Hospital is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Taiwan register, as of the registry sync on 17 November 2026. Completed and withdrawn studies are not counted.

Are National Yang Ming Chiao Tung University Hospital trials recruiting?

Not at the moment. None of its 4 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.

Which drugs is National Yang Ming Chiao Tung University Hospital testing?

Its current trials name 1 drug or biological as interventions. The most frequent are Atropine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 17 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.